Ravandi, F., Cortes, J. E., Jones, D., Faderl, S., Garcia-Manero, G., Konopleva, M. Y., . . . Kantarjian, H. M. (2010). Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia. American Society of Clinical Oncology.
Citación estilo ChicagoRavandi, Farhad, et al. Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia. American Society of Clinical Oncology, 2010.
Cita MLARavandi, Farhad, et al. Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia. American Society of Clinical Oncology, 2010.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.